Wardwizard Healthcare Approves ₹12.5 Crore Preferential Warrant Issue

Board approved a preferential private placement of up to 1.25 crore fully convertible warrants at Rs 10 each, aggregating up to Rs 12.5 Cr, subject to shareholder and regulatory approvals. Each warrant converts into one equity share within 18 months. The issue includes 70 lakh warrants for promoter/promoter-group allottees and 55 lakh for non-promoter allottees. The company will increase authorised share capital from Rs 7.5 Cr to Rs 25 Cr. Proceeds are intended for growth, working capital, general corporate purposes and investment in promoter-group entities including Wardwizard Medicare. Full conversion would substantially dilute existing shareholders, with promoter/promoter-group ownership rising to 55.91% from 51.23%. Detailed deployment, valuation and terms of investments in promoter-group entities remain undisclosed; conversion is subject to allotment and shareholder approval.